↓ Skip to main content

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

Overview of attention for article published in Journal of Clinical Oncology, November 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
7 news outlets
twitter
22 X users
patent
1 patent
facebook
2 Facebook pages

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
120 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
Published in
Journal of Clinical Oncology, November 2016
DOI 10.1200/jco.2015.66.2080
Pubmed ID
Authors

Kala Visvanathan, MaryJo S Fackler, Zhe Zhang, Zoila A Lopez-Bujanda, Stacie C Jeter, Lori J Sokoll, Elizabeth Garrett-Mayer, Leslie M Cope, Christopher B Umbricht, David M Euhus, Andres Forero, Anna M Storniolo, Rita Nanda, Nancy U Lin, Lisa A Carey, James N Ingle, Saraswati Sukumar, Antonio C Wolff

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 119 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 14%
Student > Ph. D. Student 16 13%
Other 14 12%
Student > Master 12 10%
Student > Doctoral Student 6 5%
Other 26 22%
Unknown 29 24%
Readers by discipline Count As %
Medicine and Dentistry 34 28%
Biochemistry, Genetics and Molecular Biology 27 23%
Agricultural and Biological Sciences 12 10%
Nursing and Health Professions 3 3%
Arts and Humanities 2 2%
Other 7 6%
Unknown 35 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2023.
All research outputs
#699,970
of 25,382,440 outputs
Outputs from Journal of Clinical Oncology
#1,583
of 22,051 outputs
Outputs of similar age
#14,243
of 415,210 outputs
Outputs of similar age from Journal of Clinical Oncology
#61
of 276 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,051 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 415,210 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.